abstract |
The present invention is directed to cinoline and quinazoline compounds of the formula (I) which are PDE10 inhibitors, pharmaceutical compounds containing them and process for preparing them. The invention is also directed to methods for treating diseases treatable by the PDE10 enzyme, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like. |